← Back to Metabolic Health
17 · Metabolic Health

The Early Warning Signs Worth Catching

Insulin resistance, fatty liver, and rising cholesterol often develop quietly — but caught early, they are among the most reversible conditions in medicine.

May 20265 min readClinician-reviewed

Metabolic health — how the body handles blood sugar, fats, and energy — tends to change silently, which is exactly why it is so often missed until it is more advanced. Insulin resistance, an early step on the path toward type 2 diabetes, can show up as fatigue after meals, sugar cravings, weight gain around the middle, skin tags, or darkened patches of skin at the neck and armpits. At this stage it is frequently reversible, yet it is often seen as simply 'weight' rather than a treatable metabolic state.

Metabolic-associated fatty liver disease is usually silent in its early stages, sometimes flagged only by mildly raised liver enzymes that are not always followed up — yet it too is reversible when addressed early. Raised cholesterol, especially inherited forms, produces no symptoms while quietly increasing cardiovascular risk, and that risk is frequently underestimated in women.

These conditions are closely linked to PCOS and to the hormonal shifts of menopause, making metabolic health particularly relevant across a woman's life. Simple blood tests can detect them early, when lifestyle changes — and treatment where needed — make the greatest difference.

Symptoms worth paying attention to
  • 01Fatigue after meals, sugar cravings, or weight gain around the middle
  • 02Skin tags or darkened skin at the neck or armpits
  • 03Mildly abnormal liver or cholesterol results
  • 04PCOS, family history, or previous gestational diabetes
When to speak to a healthcare professional

If you have PCOS, a family history of diabetes or heart disease, or a previous gestational diabetes diagnosis, ask about metabolic checks — blood sugar (HbA1c), lipids, and liver tests — even if you feel well.

Sources · Peer-reviewed: gestational diabetes & long-term metabolic risk (PMC 2025) · NICE NG49 — NAFLD · Diabetes UK